Document Detail

Immune Modulation of Resistance Artery Remodeling.
MedLine Citation:
PMID:  21740527     Owner:  NLM     Status:  Publisher    
Low-grade inflammation plays a role in cardiovascular disease. The innate and the adaptive immune response participate in mechanisms that contribute to inflammatory responses. It has been increasingly appreciated that different subsets of lymphocytes and the cytokines they produce modulate the vascular remodeling that occurs in cardiovascular disease. Effector T cells such as T-helper (Th) 1 (interferon-γ-producing) and Th2 lymphocytes (that produce interleukin-4), as well as Th17 (that produce interleukin-17), and T suppressor lymphocytes including regulatory T cells (Treg), which express the transcription factor forkhead box P3 (Foxp3) are involved in the remodeling of small arteries that occurs under the action of angiotensin II, deoxycorticosterone-salt and aldosterone-salt, as well as in models of hypertension such as the Dahl-salt sensitive rat. The mechanism whereby the immune system is activated is unclear, but it has been suggested that neo-antigens may be generated by elevation of blood pressure or other stimuli, leading to activation of the immune response. Activated Th1 may contribute to vascular remodeling directly on blood vessels via effects of the cytokines produced, or indirectly by actions on the kidney. The protective effect of Treg may be mediated similarly directly or via renal effects. These data offer promise for discovery of new therapeutic targets to ameliorate vascular remodeling, which could lead to improved outcomes in cardiovascular disease in humans.
Ernesto L Schiffrin
Related Documents :
22018827 - Systemic inflammation, cellular influx and up-regulation of ovarian vcam-1 expression i...
21772667 - Foxp3 expression in liver correlates with the degree but not the cause of inflammation.
21707997 - Toxoplasma gondii peroxiredoxin promotes altered macrophage function, caspase-1-depende...
22043907 - Upregulation of micro rna-146a (mirna-146a), a marker for inflammatory neurodegeneratio...
19440357 - Leishmania infantum amastigotes enhance hiv-1 production in cocultures of human dendrit...
19917687 - Deciphering the immune function and regulation by a tlr of the cytokine emapii in the l...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-8
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  -     ISSN:  1742-7843     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.
Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Predictive Value of Epidermal Growth Factor Receptor (EGFR) Expression for Sensitivity to Vinore...
Next Document:  Foetal Exposure to Food and Environmental Carcinogens in Humans.